⚠️
Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
Poor quality product administered
8,576 total reports0.1% serious outcomes
Share
8,576
Total Reports
2
Deaths
3
Hospitalizations
0.1
Severity Rate
% serious outcomes
About Poor quality product administered Reports
Poor quality product administered has been reported 8,576 times in VAERS from 1990 to 2026.
Of these reports, 2 were associated with death (0.02%) and 3 involved hospitalization.
The overall serious outcome rate (death or hospitalization) for reports mentioning Poor quality product administered is 0.1%.
Understanding Poor quality product administered in VAERS
•Temporal association only: These reports show Poor quality product administered occurred after vaccination, not necessarily because of vaccination.
•Background rates matter: Many symptoms occur naturally at baseline rates in the population, unrelated to vaccination.
•Reporting variability: Medical terminology may be used differently by various healthcare providers and over time.
•Investigation needed: High-frequency reports may trigger further epidemiological studies to determine causation.
What This Data Shows
Most Associated Vaccines: The vaccines most frequently mentioned in reports with Poor quality product administered. This may reflect usage patterns, not causation.
Severity Patterns: The percentage of reports that involve serious outcomes can help prioritize safety investigations.
Reporting Trends: Changes in reporting frequency over time may reflect increased awareness, media attention, or actual safety signals.
Most Associated Vaccines
1. COVID197,701
2. COVID19-2474
3. IPV240
4. FLU4144
5. TDAP59
6. HIBV59
7. UNK56
8. MEN43
9. DTAP30
10. TD27
Quick Facts
Reports:8,576
Deaths:2
Hospitalizations:3
Mortality Rate:0.02%
Severity Rate:0.1%
Related Analysis
Explore Further
Data Source
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.